MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511133421 A) filed by Manjusha Dhande Borde; Ipseeta Ray Mohanty; Rajesh Kumar Suman; and Shalini Vijay Rakhade, Navi Mumbai, Maharashtra, on Dec. 30, 2025, for 'a cardioprotective pharmaceutical composition comprising terminalia arjuna and metformin acting through dpp-4 inhibition for the management of diabetes-associated myocardial infarction.'
Inventor(s) include Manjusha Dhande Borde; Ipseeta Ray Mohanty; Rajesh Kumar Suman; and Shalini Vijay Rakhade.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a cardiop...